Product Overview / Description

TEMPRA-C DS SUSPENSION contains a combination of Paracetamol 250 mg + Phenylephrine Hydrochloride 5 mg + Chlorpheniramine Maleate 2 mg per 5 mL in a flavoured oral suspension base.

The formulation combines an analgesic/antipyretic component with a nasal decongestant and antihistamine. Comparable formulations with the same 250 mg + 5 mg + 2 mg strength are used for symptomatic management of common-cold symptoms in children.

The product artwork identifies TEMPRA-C DS as a 60 mL suspension and uses child-oriented packaging imagery, supporting its placement in the Pedia segment of your Positive Medicare catalogue.

For your B2B pharmaceutical website, the product can be presented for pharmaceutical distributors, stockists, retailers, healthcare professionals and prospective franchise partners who need to verify the product’s composition, strength, dosage form and pack presentation before making a business enquiry.

Availability and Franchise Enquiries

Contact the Positive Medicare team for the latest pack presentation, order quantity, territory availability and commercial terms.

Pharmaceutical distributors, stockists, retailers and prospective franchise partners can enquire about product availability and related pharmaceutical business opportunities.

Important

This page is intended for healthcare professionals and pharmaceutical business enquiries. It does not provide individual treatment, dosage or prescribing advice. Products containing Paracetamol, Phenylephrine Hydrochloride and Chlorpheniramine Maleate should be used according to approved product labelling and under the direction of a qualified healthcare professional.